MASS Cash-Secured Put Strategy
MASS (908 Devices Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
MASS (908 Devices Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $285.1M, a beta of 0.57 versus the broader market, a 52-week range of 4.21-9.34, average daily share volume of 276K, a public-listing history dating back to 2020, approximately 246 full-time employees. These structural characteristics shape how MASS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.57 indicates MASS has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a cash-secured put on MASS?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current MASS snapshot
As of May 15, 2026, spot at $6.97, ATM IV 120.80%, IV rank 33.64%, expected move 34.63%. The cash-secured put on MASS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this cash-secured put structure on MASS specifically: MASS IV at 120.80% is mid-range versus its 1-year history, so the credit collected on a MASS cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 34.63% (roughly $2.41 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MASS expiries trade a higher absolute premium for lower per-day decay. Position sizing on MASS should anchor to the underlying notional of $6.97 per share and to the trader's directional view on MASS stock.
MASS cash-secured put setup
The MASS cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MASS near $6.97, the first option leg uses a $6.62 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MASS chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MASS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $6.62 | N/A |
MASS cash-secured put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
MASS cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on MASS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use cash-secured put on MASS
Cash-secured puts on MASS earn premium while a trader waits to acquire MASS stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning MASS.
MASS thesis for this cash-secured put
The market-implied 1-standard-deviation range for MASS extends from approximately $4.56 on the downside to $9.38 on the upside. A MASS cash-secured put lets a trader earn premium while waiting to acquire MASS at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current MASS IV rank near 33.64% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on MASS should anchor more to the directional view and the expected-move geometry. As a Healthcare name, MASS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MASS-specific events.
MASS cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MASS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MASS alongside the broader basket even when MASS-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on MASS carry tail risk when realized volatility exceeds the implied move; review historical MASS earnings reactions and macro stress periods before sizing. Always rebuild the position from current MASS chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on MASS?
- A cash-secured put on MASS is the cash-secured put strategy applied to MASS (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With MASS stock trading near $6.97, the strikes shown on this page are snapped to the nearest listed MASS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MASS cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the MASS cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 120.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MASS cash-secured put?
- The breakeven for the MASS cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MASS market-implied 1-standard-deviation expected move is approximately 34.63%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on MASS?
- Cash-secured puts on MASS earn premium while a trader waits to acquire MASS stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning MASS.
- How does current MASS implied volatility affect this cash-secured put?
- MASS ATM IV is at 120.80% with IV rank near 33.64%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.